Source: Annual Congress 2013 –COPD: new markers of diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Sohal, D. Tan, H. K. Muller, D. Reid, E. H. Walters (Hobart, Brisbane, Australia). Neutrophil numbers are decreased in bronchial biopsies from patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 606

Member's Comments

No comment yet.

Related content which might interest you: Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Myofibroblast expression in airways and alveoli is affected by smoking and COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Mucociliary function in bronchial epithelium of COPD and non-COPD patients: In vitro assessment of the effects of fluid restriction Source: International Congress 2014 – Cell biology 2014 Year: 2014 Cell composition of induced sputum in patients with uncontrolled asthma and its participation in the formation of cold airway hyperresponsiveness Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Airway inflammation in patients with different levels of asthma control Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Mapping of eosinophil and basophils in COPD lung tissues Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 IgA expression in peribronchial and lung follicular B cells from COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014